CYRX
NASDAQ · Life Sciences Tools & Services
Cryoport Inc
$8.72
+0.12 (+1.40%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 231.71M | 229.74M | 134.05M | 137.31M | 144.41M |
| Net Income | -116,430,225 | -103,893,716 | 23.25M | 19.23M | 25.18M |
| EPS | — | — | — | — | — |
| Profit Margin | -50.3% | -47.7% | 17.3% | 14.0% | 17.4% |
| Rev Growth | +0.9% | +0.9% | -3.6% | +13.1% | +7.3% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 72.82M | 72.82M | 205.91M | 221.73M | 216.61M |
| Total Equity | 145.48M | 145.48M | 253.44M | 262.41M | 301.43M |
| D/E Ratio | 0.50 | 0.50 | 0.81 | 0.84 | 0.72 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -89,798,576 | -84,581,248 | 39.47M | 43.82M | 47.91M |
| Free Cash Flow | — | — | 13.04M | 11.97M | 10.29M |